Current Ratio of Spero Therapeutics, Inc. from 30 Jun 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Spero Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2018 to 30 Sep 2025.
  • Spero Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 275%, a 9.1% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Spero Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 275% -27% -9.1% 30 Sep 2025
Q2 2025 262% -68% -21% 30 Jun 2025
Q1 2025 252% -127% -34% 31 Mar 2025
Q4 2024 270% -141% -34% 31 Dec 2024
Q3 2024 302% -162% -35% 30 Sep 2024
Q2 2024 330% -126% -28% 30 Jun 2024
Q1 2024 379% -47% -11% 31 Mar 2024
Q4 2023 411% +122% +42% 31 Dec 2023
Q3 2023 464% +130% +39% 30 Sep 2023
Q2 2023 456% +59% +15% 30 Jun 2023
Q1 2023 426% -22% -4.9% 31 Mar 2023
Q4 2022 289% -500% -63% 31 Dec 2022
Q3 2022 334% -481% -59% 30 Sep 2022
Q2 2022 397% -431% -52% 30 Jun 2022
Q1 2022 448% -275% -38% 31 Mar 2022
Q4 2021 790% +159% +25% 31 Dec 2021
Q3 2021 815% +325% +66% 30 Sep 2021
Q2 2021 828% +370% +81% 30 Jun 2021
Q1 2021 723% +159% +28% 31 Mar 2021
Q4 2020 631% -125% -16% 31 Dec 2020
Q3 2020 490% -591% -55% 30 Sep 2020
Q2 2020 458% -840% -65% 30 Jun 2020
Q1 2020 564% -676% -55% 31 Mar 2020
Q4 2019 756% -409% -35% 31 Dec 2019
Q3 2019 1081% -137% -11% 30 Sep 2019
Q2 2019 1298% +318% +32% 30 Jun 2019
Q1 2019 1240% 31 Mar 2019
Q4 2018 1165% 31 Dec 2018
Q3 2018 1218% 30 Sep 2018
Q2 2018 980% 30 Jun 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.